Inflammatory Biomarkers in Patients with Asymptomatic Primary Hyperparathyroidism

被引:19
作者
Emam, Ahmed Alsayed [1 ]
Mousa, Sabela Gomaa
Ahmed, Karema Yousif
Al-Azab, Adel A. [2 ]
机构
[1] Al Azhar Univ, Dept Internal Med, Natl Res Ctr, Cairo, Egypt
[2] Ain Shams Univ, Cairo, Egypt
关键词
Asymptomatic primary hyperparathyroidism; Highly sensitive C-reactive protein; Interleukin-6; C-REACTIVE PROTEIN; HORMONE-RELATED PROTEIN; NECROSIS-FACTOR-ALPHA; CIRCULATING LEVELS; BONE-RESORPTION; INTERLEUKIN-6; MARKERS; PEPTIDE; RISK;
D O I
10.1159/000334588
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess highly sensitive C-reactive protein (hs-CRP) and interleukin-6 (IL-6) as inflammatory biomarkers in patients with asymptomatic primary hyperparathyroidism (PHPT). Materials and Methods: A total of 26 patients with asymptomatic PHPT and 22 age- and sex-matched individuals as a control group were recruited for the study. Corrected serum calcium, phosphorus, alkaline phosphatase, serum 25-hydroxyvitamin D, intact parathyroid hormone (PTH), hs-CRP and IL-6 were measured for all subjects. Results: Serum hs-CRP and IL-6 were significantly higher in asymptomatic PHPT patients than in the control group (hs-CRP: 4.15 +/- 0.54 vs. 2.24 +/- 0.11 mg/l; IL-6: 4.50 +/- 0.80 vs. 2.56 +/- 0.29 pg/ml; p < 0.001). Moreover, in asymptomatic PHPT patients, serum PTH was significantly correlated with hs-CRP and IL-6 (r = 0.820, p < 0.001 and r = 0.787, p < 0.001, respectively). Conclusion: Inflammatory biomarkers were higher in patients with asymptomatic PHPT than in controls. Moreover, serum PTH was significantly correlated with inflammatory biomarkers which may suggest a subclinical inflammatory response in this group of patients. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:249 / 253
页数:5
相关论文
共 29 条
  • [1] Cardiovascular Biology of Interleukin-6
    Abeywardena, Mahinda Y.
    Leifert, Wayne R.
    Warnes, Kirsty E.
    Varghese, Jose N.
    Head, Richard J.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (15) : 1809 - 1821
  • [2] Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism
    Almqvist, Erik G.
    Bondeson, Anne-Greth
    Bondeson, Lennart
    Svensson, Johan
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2011, 71 (02) : 139 - 144
  • [3] Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop
    Bilezikian, John P.
    Khan, Aliya A.
    Potts, John T., Jr.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02) : 335 - 339
  • [4] Asymptomatic primary hyperparathyroidism
    Birkenhager, JC
    Bouillon, R
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1996, 72 (848) : 323 - 326
  • [5] Brown EM, 2002, J BONE MINER RES, V17, pN24
  • [6] Tumor necrosis factor alpha and interleukin 6 productions in response to platelet-activating factor in chronic hepatitis B virus infection
    Buke, AC
    Buke, M
    Altuglu, IE
    Ciceklioglu, M
    Kamcioglu, S
    Karakartal, G
    Huseyinov, A
    [J]. MEDICAL PRINCIPLES AND PRACTICE, 2004, 13 (05) : 273 - 276
  • [7] The Evolving Role of C-Reactive Protein in Atherothrombosis
    Devaraj, Sridevi
    Singh, Uma
    Jialal, Ishwarlal
    [J]. CLINICAL CHEMISTRY, 2009, 55 (02) : 229 - 238
  • [8] Parathyroid hormone-related protein is induced in the adult liver during endotoxemia and stimulates the hepatic acute phase response
    Funk, JL
    Moser, AH
    Grunfeld, C
    Feingold, KR
    [J]. ENDOCRINOLOGY, 1997, 138 (07) : 2665 - 2673
  • [9] Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation
    Gabay, C
    Kushner, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) : 448 - 454
  • [10] Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption - A clinical research center study
    Grey, A
    Mitnick, MA
    Shapses, S
    Ellison, A
    Gundberg, C
    Insogna, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) : 3450 - 3454